secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sotera Health Co (SHC)
CIK:        0001822479
Form:       8-K
Filed at:   2026-08-06T11:19:04+00:00
Accession:  0001822479-26-000044
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sotera Health Q2 net income jumps to $54M; raises FY 2026 revenue and EBITDA guidance
--------------------------------------------------------------------------------

- Q2 net revenues +9.2% (+8.0% constant currency); net income $54M ($0.19 diluted EPS) vs $8M ($0.03) in Q2 2025.
- Adjusted EBITDA +10.0% (+8.7% constant currency); Adjusted EPS $0.26, up 30% per diluted share.
- Raises FY 2026 outlook: net revenue growth 5.25%-6.75%, Adjusted EBITDA growth 5.75%-7.25% on constant currency basis.
- Segment constant currency growth: Sterigenics 7.0%, Nordion 16.7%, Nelson Labs 5.4%; Net leverage ratio 3.0x, liquidity ~$950M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822479/000182247926000044/0001822479-26-000044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822479/000182247926000044/shc-20260806.htm
  HTML page:      https://secwatch.observer/filing/0001822479-26-000044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer